Story perspectives

AI Tool popEVE Revolutionizes Rare Disease Diagnosis

11/26/2025

Summary

Story summary

Harvard Medical School researchers developed popEVE, an AI tool that scores genetic variants to prioritize a genome for diagnosing rare diseases.
In testing, popEVE accurately distinguished harmful from benign variants and identified 123 new candidate genes linked to developmental disorders.
The tool shows no ancestry bias, enabling effectiveness across diverse genetic backgrounds.
Researchers are optimistic about clinical use, aiming to improve diagnosis and treatment for patients undiagnosed by traditional methods.

1 of 1

Story summary

Harvard Medical School researchers developed popEVE, an AI tool that scores genetic variants to prioritize a genome for diagnosing rare diseases.
In testing, popEVE accurately distinguished harmful from benign variants and identified 123 new candidate genes linked to developmental disorders.
The tool shows no ancestry bias, enabling effectiveness across diverse genetic backgrounds.
Researchers are optimistic about clinical use, aiming to improve diagnosis and treatment for patients undiagnosed by traditional methods.